Syra Health Marks First Anniversary as a Publicly Traded Company with Strong Successes and Growth
Syra Health Corp. (NASDAQ: SYRA) is celebrating its first anniversary as a publicly traded company, highlighting significant achievements and growth. The healthcare technology company has increased quarterly revenue by 47% in Q1 2024 and 101% in Q2 2024 compared to the previous year. Syra Health has expanded its presence to 24 states and is a subcontractor on two federal contracts with a combined ceiling value of $118 Billion.
The company has secured multiple contract wins across all business units, including recent Healthcare Workforce contracts in Delaware, Florida, and Kansas. Syra Health successfully raised $2.1 Million in capital for the development of Syrenity, their mental health app, and other initiatives. The company is focusing on high-margin business units, implementing cost reduction strategies, and working towards profitability while continuing to innovate in healthcare solutions.
Syra Health Corp. (NASDAQ: SYRA) celebra il suo primo anniversario come azienda quotata in borsa, evidenziando realizzazioni e crescita significative. L'azienda tecnologica healthcare ha incrementato i ricavi trimestrali del 47% nel primo trimestre del 2024 e del 101% nel secondo trimestre del 2024 rispetto all'anno precedente. Syra Health ha ampliato la sua presenza a 24 stati ed è un subappaltatore in due contratti federali con un valore complessivo di $118 miliardi.
L'azienda ha ottenuto numerosi successi contrattuali in tutte le unità aziendali, inclusi contratti recenti per la forza lavoro sanitaria in Delaware, Florida e Kansas. Syra Health ha raccolto con successo $2,1 milioni in capitale per lo sviluppo di Syrenity, la loro app per la salute mentale, e altre iniziative. L'azienda si sta concentrando su unità aziendali ad alta redditività, implementando strategie di riduzione dei costi e lavorando verso la redditività, continuando a innovare nelle soluzioni sanitarie.
Syra Health Corp. (NASDAQ: SYRA) está celebrando su primer aniversario como empresa cotizada en bolsa, destacando logros y crecimiento significativos. La empresa de tecnología en salud ha incrementado sus ingresos trimestrales en un 47% en el primer trimestre de 2024 y un 101% en el segundo trimestre de 2024 en comparación con el año anterior. Syra Health ha ampliado su presencia a 24 estados y es subcontratista en dos contratos federales con un valor máximo combinado de $118 mil millones.
La empresa ha asegurado múltiples victorias en contratos en todas las unidades de negocio, incluidos contratos recientes de fuerza laboral sanitaria en Delaware, Florida y Kansas. Syra Health logró recaudar $2,1 millones en capital para el desarrollo de Syrenity, su aplicación de salud mental, y otras iniciativas. La empresa se centra en unidades comerciales de alto margen, implementando estrategias de reducción de costos y trabajando hacia la rentabilidad mientras continúa innovando en soluciones de salud.
Syra Health Corp. (NASDAQ: SYRA)는 상장된 회사로서 첫 번째 기념일을 축하하며, 중요한 성과와 성장을 강조합니다. 이 헬스케어 기술 회사는 2024년 1분기 매출을 전년 대비 47% 증가시키고 2분기에는 101% 증가시켰습니다. Syra Health는 24개 주로 그 영역을 확장하였으며, 총 1180억 달러의 가치를 가진 두 개의 연방 계약에서 하청업체로 활동하고 있습니다.
회사는 델라웨어, 플로리다 및 캔사스에서 최근 헬스케어 인력 계약을 포함하여 모든 사업 부서에서 여러 계약을 체결한 성과를 얻었습니다. Syra Health는 210만 달러의 자본을 성공적으로 조달하여 그들의 정신 건강 앱 Syrenity와 기타 프로젝트의 개발에 투자하고 있습니다. 회사는 고수익 사업 부문에 집중하고 있으며, 비용 절감 전략을 시행하고 수익성을 향해 나아가면서 헬스케어 솔루션의 혁신을 지속하고 있습니다.
Syra Health Corp. (NASDAQ: SYRA) célèbre son premier anniversaire en tant qu'entreprise cotée en bourse, mettant en avant des réalisations et une croissance significatives. L'entreprise de technologie de la santé a augmenté son chiffre d'affaires trimestriel de 47 % au premier trimestre 2024 et de 101 % au deuxième trimestre 2024 par rapport à l'année précédente. Syra Health a élargi sa présence à 24 États et est sous-traitant de deux contrats fédéraux d'une valeur plafond combinée de 118 milliards de dollars.
L'entreprise a sécurisé de nombreux contrats remportés dans toutes les unités commerciales, y compris des contrats récents pour la main-d'œuvre en santé dans le Delaware, la Floride et le Kansas. Syra Health a réussi à lever 2,1 millions de dollars en capital pour le développement de Syrenity, leur application de santé mentale, et d'autres initiatives. L'entreprise se concentre sur des unités commerciales à forte marge, met en œuvre des stratégies de réduction des coûts et travaille à la rentabilité tout en continuant d'innover dans les solutions de santé.
Syra Health Corp. (NASDAQ: SYRA) feiert sein erstes Jubiläum als börsennotiertes Unternehmen und hebt dabei bedeutende Erfolge und Wachstumsleistungen hervor. Das Unternehmen für Gesundheitstechnologie hat den vierteljährlichen Umsatz im 1. Quartal 2024 um 47 % und im 2. Quartal 2024 um 101 % im Vergleich zum Vorjahr gesteigert. Syra Health hat seine Präsenz auf 24 Bundesstaaten ausgeweitet und ist Subunternehmer in zwei Bundesverträgen mit einem Gesamtwert von 118 Milliarden Dollar.
Das Unternehmen hat in allen Geschäftsbereichen mehrere Vertragsgewinne erzielt, darunter kürzlich Verträge zur Gesundheitsversorgung in Delaware, Florida und Kansas. Syra Health hat erfolgreich 2,1 Millionen Dollar Kapital für die Entwicklung von Syrenity, ihrer App für psychische Gesundheit, und andere Initiativen gesammelt. Das Unternehmen konzentriert sich auf margenstarke Geschäftseinheiten, implementiert Kostensenkungsstrategien und arbeitet auf die Rentabilität hin, während es weiterhin in Gesundheitslösungen innoviert.
- None.
- None.
"It's exciting to look back on what the Syra Health team has achieved over the past year since our Nasdaq listing," said Dr. Deepika Vuppalanchi, CEO, Syra Health. "We have increased our revenues and are strategically taking actions to reduce operating expenses. We are expanding our impact across various geographies and business units, always with a focus on making a real difference in the communities we serve. By focusing on our high-margin areas, we have not only boosted our profit margins but also continued to invest in innovative solutions that will shape the future of healthcare. Our legacy business unit, Healthcare Workforce, remains the cornerstone that fuels these advancements, allowing us to push boundaries and improve health outcomes every step of the way."
Syra Health's achievements since the Company's 2023 IPO:
- Achieved record quarterly revenue growth of
47% in Q1 2024 and101% in Q2 2024 compared to the respective quarters in the previous year - Enhanced profit margins by concentrating on high-margin business units
- Active contracts in 24 states across the nation
- Subcontractor to prime vendors on two federal contracts with the Defense Health Agency and Health and Human Services, totaling
in ceiling value. Monetization will occur upon receipt of task orders$118 Billion - Continues to secure multiple contract wins across all of the company's business units including recent Healthcare Workforce wins in
Delaware ,Florida , andKansas and a contract extension in Washington D.C. with ceiling value up to$4 Million - Successfully raised
in capital to fund the additional development of Syrenity, our innovative mental health app, along with robust sales and marketing initiatives, and ongoing research and development efforts$2.1 Million - Implementations of several high-profile state government projects are underway
- Strategic restructuring of operations designed to drive cost reductions and enhance operational efficiencies
- Introduced the "Roadmap to Greatness" initiative internally outlining commercial, operational, innovation, and people goals for the company
"From a financial standpoint, we have significantly increased our revenues over the past year while actively working to reduce our operating expenses and increase operational efficiencies," said Priya Prasad, CFO, Syra Health. "Our team is dedicated to delivering innovative healthcare solutions, whether through services or technology products. We are committed to improving health and progressing on our journey to profitability."
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company powering better health in challenging areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology products. Syra Health's offerings are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and the government. For more information, please visit www.syrahealth.com.
FORWARD-LOOKING STATEMENTS
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts
For Media or Investor Inquiries:
Christine Drury
PR/IR and Marketing Director
Syra Health
463-345-5180
christined@syrahealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-marks-first-anniversary-as-a-publicly-traded-company-with-strong-successes-and-growth-302263437.html
SOURCE Syra Health
FAQ
What was Syra Health's revenue growth in Q2 2024 compared to the previous year?
How many states does Syra Health have active contracts in as of October 2024?
What is the total ceiling value of the federal contracts Syra Health is involved in?
How much capital did Syra Health raise for its mental health app and other initiatives?